Compass Therapeutics (CMPX) Notes Payables (2018 - 2020)

Compass Therapeutics (CMPX) reported Notes Payables of $103110.0 for Q1 2020, up 42.96% on a YoY basis from $72125.0 in Q2 2019, and down 79.13% sequentially from $494000.0 in Q4 2019.

Compass Therapeutics (CMPX) Notes Payables (2018 - 2020) Analysis & Trends

Compass Therapeutics (CMPX) has 3 years of Notes Payables data on file, last reported at $103110.0 in Q1 2020.

  • For the quarter ending Q1 2020, Notes Payables rose 42.96% year-over-year to $103110.0; the trailing twelve-month figure through Mar 2020 stood at $103110.0 (up 42.96% YoY), and the FY2020 full-year result was $103110.0, up 42.96% from the prior year.
  • Notes Payables slipped to $103110.0 in Q1 2020, from $494000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $494000.0 in Q4 2019 to a low of $34525.0 in Q1 2018.
  • A 3-year average of $113652.2 and a median of $72125.0 in 2019 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables soared 695.17% in 2019 and soared 42.96% in 2020, its largest moves.
  • Tracing CMPX's Notes Payables over 3 years: stood at $62125.0 in 2018, then soared by 695.17% to $494000.0 in 2019, then slumped by 79.13% to $103110.0 in 2020.
  • Business Quant data shows CMPX's Notes Payables at $103110.0 in Q1 2020, $494000.0 in Q4 2019, and $85610.0 in Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Compass Therapeutics 395.17 Mn 200.48 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2020 103,110.00
Dec 31, 2019 494,000.00
Sep 30, 2019 85,610.00
Jun 30, 2019 72,125.00
Mar 31, 2019 72,125.00
Dec 31, 2018 62,125.00
Sep 30, 2018 49,625.00
Jun 30, 2018 49,625.00
Mar 31, 2018 34,525.00